Comparison of inflammation-related hematologic indices for predicting metabolic syndrome in adults
Özet
Aim: It was planned to evaluate different hematologic indices (neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), lymphocyte/monocyte ratio (LMR), lymphocyte/high-density lipoprotein to cholesterol ratio (LHR), neutrophil/high-density lipoprotein to cholesterol ratio (NHR), and monocyte/high-density lipoprotein to cholesterol ratio (MHR)) associated with inflammation in predicting metabolic syndrome in adults and to predict which marker is the better predictor. Materials and methods: This study comprised 399 adults between the ages of 18 and 65. Bodyweight, height, waist circumference, and blood pressure were measured; fasting blood glucose, total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, C-reactive protein, and hemogram values were analyzed. The International Diabetes Federation criteria were used to define metabolic syndrome. Results: The study included 133 (33.3%) males and 266 (66.4%) females with an average age of 54.3 ± 11.8 years. The prevalence of metabolic syndrome is 58.6% (male 44.3%; female 65.7%). For both men (AUC = 0.730, cutoff = 4.5) and women (AUC = 0.669, cutoff = 4.2), the NHR index has the highest AUC. LHR has the second-highest metabolic syndrome determination in men (AUC = 0.647, cutoff = 6.9). Women’s LHR (AUC = 0.626, cutoff = 6.4) and LMR (AUC = 0.757, cutoff = 4.9) had the second and third highest AUCs, respectively, while NLR and PLR were not significant in either gender (p > 0.05). Conclusion: The NHR index is a strong predictor of metabolic syndrome. In men, the NHR index is a better predictor of metabolic syndrome than the LHR index, and in women, the NHR index is better than the LHR and LMR. © 2022, The Author(s), under exclusive licence to Research Society for Study of Diabetes in India.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Yilmaz, Sevil Karahan | |
| dc.contributor.author | Özçiçek, Fatih | |
| dc.date.accessioned | 2026-10-18T20:27:22.688177767Z | |
| dc.date.available | 2026-10-18T20:27:22.688177767Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Aim: It was planned to evaluate different hematologic indices (neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), lymphocyte/monocyte ratio (LMR), lymphocyte/high-density lipoprotein to cholesterol ratio (LHR), neutrophil/high-density lipoprotein to cholesterol ratio (NHR), and monocyte/high-density lipoprotein to cholesterol ratio (MHR)) associated with inflammation in predicting metabolic syndrome in adults and to predict which marker is the better predictor. Materials and methods: This study comprised 399 adults between the ages of 18 and 65. Bodyweight, height, waist circumference, and blood pressure were measured; fasting blood glucose, total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, C-reactive protein, and hemogram values were analyzed. The International Diabetes Federation criteria were used to define metabolic syndrome. Results: The study included 133 (33.3%) males and 266 (66.4%) females with an average age of 54.3 ± 11.8 years. The prevalence of metabolic syndrome is 58.6% (male 44.3%; female 65.7%). For both men (AUC = 0.730, cutoff = 4.5) and women (AUC = 0.669, cutoff = 4.2), the NHR index has the highest AUC. LHR has the second-highest metabolic syndrome determination in men (AUC = 0.647, cutoff = 6.9). Women’s LHR (AUC = 0.626, cutoff = 6.4) and LMR (AUC = 0.757, cutoff = 4.9) had the second and third highest AUCs, respectively, while NLR and PLR were not significant in either gender (p > 0.05). Conclusion: The NHR index is a strong predictor of metabolic syndrome. In men, the NHR index is a better predictor of metabolic syndrome than the LHR index, and in women, the NHR index is better than the LHR and LMR. © 2022, The Author(s), under exclusive licence to Research Society for Study of Diabetes in India. | |
| dc.identifier.doi | 10.1007/s13410-022-01093-0 | |
| dc.identifier.eissn | 1998-3832 | |
| dc.identifier.endpage | 190 | |
| dc.identifier.issn | 0973-3930 | |
| dc.identifier.issue | 2 | |
| dc.identifier.scopus | 2-s2.0-85131589387 | |
| dc.identifier.startpage | 184 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/12479 | |
| dc.identifier.volume | 43 | |
| dc.identifier.wos | WOS:000807276200001 | |
| dc.language.iso | en | |
| dc.publisher | Springer | |
| dc.relation.ispartof | International Journal of Diabetes in Developing Countries | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Lymphocyte/high-density lipoprotein to cholesterol ratio | |
| dc.subject | Lymphocyte/monocyte ratio | |
| dc.subject | Metabolic syndrome | |
| dc.subject | Monocyte/high-density lipoprotein to cholesterol ratio | |
| dc.subject | Neutrophil/high-density lipoprotein to cholesterol ratio | |
| dc.subject | C reactive protein | |
| dc.subject | cholesterol | |
| dc.subject | high density lipoprotein cholesterol | |
| dc.subject | low density lipoprotein cholesterol | |
| dc.subject | triacylglycerol | |
| dc.subject | adult | |
| dc.subject | aged | |
| dc.subject | Article | |
| dc.subject | blood pressure monitoring | |
| dc.subject | body height | |
| dc.subject | body weight | |
| dc.subject | cholesterol blood level | |
| dc.subject | comparative study | |
| dc.subject | controlled study | |
| dc.subject | correlational study | |
| dc.subject | cross-sectional study | |
| dc.subject | female | |
| dc.subject | gender | |
| dc.subject | glucose blood level | |
| dc.subject | human | |
| dc.subject | International Diabetes Federation | |
| dc.subject | lymphocyte monocyte ratio | |
| dc.subject | major clinical study | |
| dc.subject | male | |
| dc.subject | metabolic syndrome X | |
| dc.title | Comparison of inflammation-related hematologic indices for predicting metabolic syndrome in adults | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 4 | |
| rdl.citation.wos | 3 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
